These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12084888)

  • 1. Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening.
    Forget R; Tozlovanu V; Iancu A; Boghen D
    Neurology; 2002 Jun; 58(12):1843-6. PubMed ID: 12084888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged orbicularis oculi activity: a major factor in apraxia of lid opening.
    Tozlovanu V; Forget R; Iancu A; Boghen D
    Neurology; 2001 Sep; 57(6):1013-8. PubMed ID: 11571326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.
    Jankovic J
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):704. PubMed ID: 8648354
    [No Abstract]   [Full Text] [Related]  

  • 4. Eyelid movements before and after botulinum therapy in patients with lid spasm.
    Manning KA; Evinger C; Sibony PA
    Ann Neurol; 1990 Nov; 28(5):653-60. PubMed ID: 2260852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apraxia of lid opening.
    Jankovic J
    Mov Disord; 1995 Sep; 10(5):686-7. PubMed ID: 8552131
    [No Abstract]   [Full Text] [Related]  

  • 6. Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results.
    Dressler D; Karapantzou C; Rohrbach S; Schneider S; Laskawi R
    J Neural Transm (Vienna); 2017 Feb; 124(2):253-257. PubMed ID: 27816991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment.
    Rana AQ; Shah R
    Acta Neurol Belg; 2012 Mar; 112(1):95-6. PubMed ID: 22427299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin therapy for apraxia of lid opening.
    Boghen D; Tozlovanu V; Iancu A; Forget R
    Ann N Y Acad Sci; 2002 Apr; 956():482-3. PubMed ID: 11960846
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin treatment of apraxia of eyelid opening in progressive supranuclear palsy: report of two cases.
    Piccione F; Mancini E; Tonin P; Bizzarini M
    Arch Phys Med Rehabil; 1997 May; 78(5):525-9. PubMed ID: 9161374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum A toxin for the so-called apraxia of lid opening.
    Lepore V; Defazio G; Acquistapace D; Melpignano C; Pomes L; Lamberti P; Livrea P; Ferrari E
    Mov Disord; 1995 Jul; 10(4):525-6. PubMed ID: 7565842
    [No Abstract]   [Full Text] [Related]  

  • 13. [The pharmacology of botulinum toxin].
    Bigalke H
    Med Monatsschr Pharm; 2002 Sep; 25(9):305-8. PubMed ID: 12369431
    [No Abstract]   [Full Text] [Related]  

  • 14. Apraxia of eyelid opening: clinical features and therapy.
    Kerty E; Eidal K
    Eur J Ophthalmol; 2006; 16(2):204-8. PubMed ID: 16703535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystonic frowning without blepharospasm.
    Hirota N; Hirota M; Mezaki T
    Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polytetrafluoroethylene frontalis suspension in blepharospasm with eyelid apraxia: an effective and well-tolerated adjunct to botulinum toxin therapy.
    Sweeney AR; Dermarkarian CR; Williams KJ; Allen RC; Yen MT
    Orbit; 2021 Feb; 40(1):39-43. PubMed ID: 32172614
    [No Abstract]   [Full Text] [Related]  

  • 20. Frontalis suspension in the treatment of essential blepharospasm unresponsive to botulinum-toxin therapy: long-term results.
    Roggenkämper P; Nüssgens Z
    Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):486-9. PubMed ID: 9285216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.